DMI-Logo
search-iconsearch-icon

Others Research Reports & Consulting

Home
>
Reports
>
Pharmaceuticals
>
Others
Browse reports
DataM has exclusive market relevance and knowledge catering our services in 60+ industries
SUB CATEGORIES
All PharmaceuticalsCardiovascularCentral Nervous SystemDermatologyEar Nose Throat DisordersGastrointestinalGenitourinary DisordersHematologyHormonal DisordersImmunologyInfectious DiseaseMetabolic DisorderDiabetes CareMouth And Dental DisordersPain ManagementMusculoskeletalNeurologyNon-Malignant DisordersNutritional DisordersOncologyOphthalmologyOther DiseasesAllergyRespiratoryWomen's and Male HealthWound Care TreatmentSyndromeOthers
FILTER
Geography
Publish Date
Themesdown
SORT
Upload Date
Upload Date
Price
Published: 2026 February 16
Targeted Protein Degradation Market - Forecast to 2033
Targeted protein degradation market to reach US$4.53B by 2033 at 32.4% CAGR, driven by PROTAC innovation, oncology demand, and precision medicine advances.
Starting from
$4350$2999
Published: 2026 May 19
Japan Biologic Drug Lifecycle Management Market Size, Trends & Forecast 2026–2033
Japan Biologic Drug Lifecycle Management Market to reach US$9.69B by 2033 at 8.6% CAGR. Trends, mAbs dominance, RWE challenges & competitive insights.
Starting from
$3175$2189
Published: 2026 February 13
Rare Neuromuscular Disorders Market Forecast 2025–2033: Market Size, Growth Trends & Leading Companies
The global rare neuromuscular disorders market reached USD 6.13 Billion in 2024 and is projected to reach USD 11.91 Billion by 2033, growing at a CAGR of 7.8%
Starting from
$4350$2999
Published: 2026 February 13
Hepatitis B & C Therapeutics Market (2025–2033)
Hepatitis B & C therapeutics market to reach US$ 20.83 Bn by 2033 at 3.4% CAGR, led by oral antivirals and NA/DAA classes; APAC fastest growth.
Starting from
$4350$2999
Published: 2026 February 20
India CAR-T Cell Therapy Market Size, Share & Forecast 2026–2033
India CAR-T cell therapy market to reach US$1.21B by 2033 at 9.7% CAGR, driven by NexCAR19, Qartemi approvals, and rising indigenous innovation.
Starting from
$3175$2189
Published: 2025 November 13
Global SCD/β-Thal Gene Therapy Outlook 2025–2033: Size, Trends, Key Players
SCD & β-thalassemia gene therapy market to reach US$380.42M by 2033 at 18.4% CAGR, led by CRISPR, ZYNTEGLO, CASGEVY, and rising approvals.
Starting from
$4350$2999
Published: 2025 November 13
Global HIV Therapeutics Market Size, Share & Forecast 2025–2033
HIV therapeutics market to reach US$57.56B by 2033 at 4.8% CAGR, led by long-acting injectables, single-tablet regimens, and wider treatment access.
Starting from
$4350$2999
Published: 2026 April 09
Hematologic Malignancy Therapeutics Market (2025–2033)
Global hematologic malignancy therapeutics market valued at USD 77.06B in 2024 is projected to reach USD 154.32B by 2033 (8.0% CAGR). Growth driven by targeted therapy approvals, immunotherapy advances, and rising blood cancer prevalence.
Starting from
$4350$2999
Published: 2025 October 30
Global Next-Generation Multiple Myeloma Therapies Market Size, Share & Forecast 2025–2033
Global market to reach US$37.07 B by 2033 at 5.4% CAGR, driven by CAR-T, bispecific antibodies, ADCs & mAb innovations transforming myeloma treatment.
Starting from
$4350$2999
Published: 2026 August 18
Competitive Landscape of the Global Obesity Therapeutics Market (2026-2035)
The global obesity therapeutics market was valued at USD 13.41 billion in 2025 and is projected to reach USD 95.09 billion by 2035, growing at a CAGR of 21.6% during the forecast period (2026–2035).
Starting from
$4350$2999